In our comprehensive analysis of HDACs in DLBCL patients using public databases, we found that the expression levels of HDAC1, HDAC2, HDAC3, HDAC6, HDAC7, HDAC8, and HDAC9 were higher in tumor tissues compared to normal control for the first time. This evidence concerns the gene HDAC3 and diffuse large B-cell lymphoma.